Vosevi

Vosevi is a prescription medication combining sofosbuvir, velpatasvir, and voxilaprevir for oral use. It is used to treat chronic hepatitis C virus (HCV) infections in adults. This combination therapy is designed for broad genotype coverage. Always consult a healthcare professional for suitability.

Vosevi is prescribed to treat chronic hepatitis C virus (HCV) infections in adults. It combines three antiviral agents to target the virus across multiple genotypes. This medication is typically used in patients who have previously been treated for HCV or have specific genotype infections. It is not suitable for everyone, including those with severe liver problems.

Vosevi works by interfering with the virus’s ability to replicate, reducing its presence in the body over time. Patients may notice improved liver function tests during treatment. The medication aims to achieve sustained virologic response, meaning the virus is no longer detectable in the blood after completion. Individual responses vary.

Vosevi should be taken exactly as prescribed by a healthcare provider. It is important to discuss your full medical history, including liver conditions and other medications, before starting treatment. Avoid alcohol and other substances that may affect the liver. Regular monitoring may be required during therapy.

Vosevi can interact with other medications, including certain anticonvulsants, antibiotics, and herbal supplements like St. John’s wort. These interactions may reduce effectiveness or increase side effects. Always inform your doctor about all drugs and supplements you are taking. Some combinations may require dose adjustments or avoidance.